Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoichi Tanaka

Showing results (141-150 of 172) with videos related to

Pageof 18
Sort By:
Blood|July 21, 2005
Myeloma cells suppress bone formation by secreting a soluble Wnt inhibitor, sFRP-2Takashi Oshima, Masahiro Abe, Jin Asano, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 27, 2012
[A case report of surgical treatment for axillary lymph node metastasis from descending colon cancer]Isao Kikuchi, Yoji Nishimura, Kazunori Nishida, et al.
Case Reports in Oncology|April 21, 2020
Heterochronous Suture Line Recurrences in the Jejunal Pouch following Total Gastrectomy for Stage II Gastric Cancer: A Case Report and Literature ReviewTakamichi Yokoe, Michio Sato, Masashi Yahagi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2007
Myeloma cell-osteoclast interaction enhances angiogenesis together with bone resorption: a role for vascular endothelial cell growth factor and osteopontinYoichi Tanaka, Masahiro Abe, Masahiro Hiasa, et al.
The Bulletin of Tokyo Dental College|February 14, 2014
A 5-year activity report from the Oral Cancer Center, Tokyo Dental CollegeNobuharu Yamamoto, Kazumichi Sato, Tomohiro Yamauchi, et al.
International Journal of Clinical Oncology|August 16, 2018
Phase II feasibility study of preoperative concurrent chemoradiotherapy with cisplatin plus 5-fluorouracil and elective lymph node irradiation for clinical stage II/III esophageal squamous cell carcinomaJun Hashimoto, Ken Kato, Yoshinori Ito, et al.
Journal of Applied Toxicology : JAT|August 7, 2023
Impact of microsampling on toxicological evaluation in rodent safety studiesKazuaki Takahashi, Norimichi Hattori, Hideaki Yokoyama, et al.
International Journal of Oncology|May 12, 2012
Copy number loss of FBXW7 is related to gene expression and poor prognosis in esophageal squamous cell carcinomaTakehiko Yokobori, Koshi Mimori, Masaaki Iwatsuki, et al.
Bioanalysis|August 16, 2023
Development and validation of qPCR methods for nucleic acid biomarkers as a drug development tool: points to considerYuchen Sun, Takahiro Nakamura, Yoshiaki Ohtsu, et al.
Molecular Pharmacology|January 20, 2023
CRISPR/Cas9-Mediated Induction of Relapse-Specific <i>NT5C2</i> and <i>PRPS1</i> Mutations Confers Thiopurine Resistance as a Relapsed Lymphoid Leukemia ModelThao Thu Thi Nguyen, Yoichi Tanaka, Masashi Sanada, et al.
Pageof 18

Showing results (141-150 of 172) with videos related to

Sort By:
Pageof 18
Blood|July 21, 2005
Myeloma cells suppress bone formation by secreting a soluble Wnt inhibitor, sFRP-2Takashi Oshima, Masahiro Abe, Jin Asano, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 27, 2012
[A case report of surgical treatment for axillary lymph node metastasis from descending colon cancer]Isao Kikuchi, Yoji Nishimura, Kazunori Nishida, et al.
Case Reports in Oncology|April 21, 2020
Heterochronous Suture Line Recurrences in the Jejunal Pouch following Total Gastrectomy for Stage II Gastric Cancer: A Case Report and Literature ReviewTakamichi Yokoe, Michio Sato, Masashi Yahagi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2007
Myeloma cell-osteoclast interaction enhances angiogenesis together with bone resorption: a role for vascular endothelial cell growth factor and osteopontinYoichi Tanaka, Masahiro Abe, Masahiro Hiasa, et al.
The Bulletin of Tokyo Dental College|February 14, 2014
A 5-year activity report from the Oral Cancer Center, Tokyo Dental CollegeNobuharu Yamamoto, Kazumichi Sato, Tomohiro Yamauchi, et al.
International Journal of Clinical Oncology|August 16, 2018
Phase II feasibility study of preoperative concurrent chemoradiotherapy with cisplatin plus 5-fluorouracil and elective lymph node irradiation for clinical stage II/III esophageal squamous cell carcinomaJun Hashimoto, Ken Kato, Yoshinori Ito, et al.
Journal of Applied Toxicology : JAT|August 7, 2023
Impact of microsampling on toxicological evaluation in rodent safety studiesKazuaki Takahashi, Norimichi Hattori, Hideaki Yokoyama, et al.
International Journal of Oncology|May 12, 2012
Copy number loss of FBXW7 is related to gene expression and poor prognosis in esophageal squamous cell carcinomaTakehiko Yokobori, Koshi Mimori, Masaaki Iwatsuki, et al.
Bioanalysis|August 16, 2023
Development and validation of qPCR methods for nucleic acid biomarkers as a drug development tool: points to considerYuchen Sun, Takahiro Nakamura, Yoshiaki Ohtsu, et al.
Molecular Pharmacology|January 20, 2023
CRISPR/Cas9-Mediated Induction of Relapse-Specific <i>NT5C2</i> and <i>PRPS1</i> Mutations Confers Thiopurine Resistance as a Relapsed Lymphoid Leukemia ModelThao Thu Thi Nguyen, Yoichi Tanaka, Masashi Sanada, et al.
Pageof 18